Zucchini et al. [24] evaluated metabolic changes with FDG-PET/CT after receiving NAC in early or locally advanced breast cancer patients, showing that early metabolic non-response was always related with histological non-responders and poor prognosis in ER-positive/HER2-negative patients. Here, ESR1 is linked to breast carcinoma.